--Bel Fuse Maintains Quarterly Cash Dividend at $0.06 per Class A Share, Payable Jan. 30, 2026 to Shareholders of Record on Jan. 15, 2026-March 2024-www.financetom.com

--Bel Fuse Maintains Quarterly Cash Dividend at $0.06 per Class A Share, Payable Jan. 30, 2026 to Shareholders of Record on Jan. 15, 2026

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

--Bel Fuse Maintains Quarterly Cash Dividend at $0.06 per Class A Share, Payable Jan. 30, 2026 to Shareholders of Record on Jan. 15, 2026

Oct 31, 2025 12:35 PM

03:00 PM EDT, 10/31/2025 (MT Newswires) --

Price: 133.80, Change: +0.27, Percent Change: +0.20

Previous page： White House's Hassett says US could take stakes in other chip companies Next page： AbbVie to Buy Gilgamesh Pharmaceuticals' Bretisilocin for Up to $1.2 Billion

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

White House's Hassett says US could take stakes in other chip companies

Aug 25, 2025

WASHINGTON, Aug 25 (Reuters) - The federal government could take stakes in other U.S. semiconductor companies or even move to other industries, White House economic adviser Kevin Hassett told CNBC in an interview on Monday following its stake in Intel ( INTC ). Hassett, asked if the Intel ( INTC ) deal was the start of a larger effort by...

AbbVie to Buy Gilgamesh Pharmaceuticals' Bretisilocin for Up to $1.2 Billion

Aug 25, 2025

09:26 AM EDT, 08/25/2025 (MT Newswires) -- AbbVie ( ABBV ) has agreed to buy Gilgamesh Pharmaceuticals' lead asset bretisilocin for up to $1.2 billion, including an upfront payment and development milestones, the companies said Monday. As part of the deal, Gilgamesh will spin off an entity to be called Gilgamesh Pharma to hold its employees and other programs, including...

Cenovus Energy Maintained at Buy at TPH After It Agrees to Acquire MEG Energy; Price Target at C$28.00

Aug 25, 2025

09:25 AM EDT, 08/25/2025 (MT Newswires) -- Tudor, Pickering, Holt on Monday reiterated its buy rating on the shares of Cenovus Energy ( CVE ) with a C$28.00 price target after the oil producer and refiner on Friday said it agreed to acquire oil-sands producer MEG Energy (MEG.TO) for $7.9-billion, including debt. We like the deal especially for CVE given...

Bank7 Renews Stock Buyback Plan

Aug 25, 2025

09:26 AM EDT, 08/25/2025 (MT Newswires) -- Bank7 ( BSVN ) said Monday the board has renewed its stock buyback plan for a two-year term. The company said the plan provides for the purchase of up to 750,000 outstanding common shares. ...